BD announces Executive Leadership Appointments

Succeeding Kaltenbach as executive vice president and president of the Life Sciences segment is Dave Hickey, who currently serves as worldwide president of the Integrated Diagnostics Solutions business.
Read More...

BD launches portable, rapid point-of-care antigen test to detect SARS-CoV-2

BD Veritor™ Plus System
The simple new assay leverages more than 25,000 BD Veritor™ instruments already used across the U.S. to immediately increase access to COVID-19 testing in frontline health care settings
Read More...

Becton Dickinson announces FDA Emergency Use Authorization for new COVID-19 diagnostic for use in U.S.

Becton Dickinson, a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen for COVID-19 (coronavirus) on site and get results in...
Read More...